Login to Your Account

Other News To Note

Thursday, February 24, 2011
Q Chip Ltd., of Cardiff, UK, announced it successfully completed preclinical studies with formulations of two leading therapeutic cancer peptides: Q-Leuprolide for prostate cancer and Q-Octreotide for acromegaly.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription